Healthcare professionals and regulatory teams have reason to pay close attention to a new clinical investigation that is set to contribute valuable insights into managing unexpected anxiety during magnetic resonance imaging (MRI) procedures. The study, sponsored by Centre Hospitalier Universitaire Dijon, evaluates the effectiveness of patient anxiety interventions such as Innovision© infotainment systems and hypnosis. Scheduled to start recruitment soon, this trial could pave the way for improved patient comfort during MRI sessions, addressing a pressing healthcare challenge in diagnostics.
In this article:
- What changed?
- Study design and objectives
- Regulatory and clinical implications
- FAQ about the clinical trial
- Conclusion
- Disclaimer
- Full announcement link
What changed?
The study titled “Use of an Infotainment System in MRI in Patients Suffering From Unexpected Anxiety” addresses a significant issue often faced during MRI procedures—anxiety management. Patients undergoing MRIs frequently experience heightened stress due to the enclosed environment and mechanical sounds, which can impact both their comfort and the exam’s diagnostic accuracy.
This research introduces novel interventions aiming to reduce such anxiety: a specialized Innovision© infotainment system, alongside hypnosis techniques. The use of standardized tools like the State Anxiety Inventory Form Y-A questionnaire ensures meticulous assessment of patient anxiety before and following intervention.
Study design and objectives
Set to begin recruitment, the clinical trial focuses on adult patients who unexpectedly suffer from increased anxiety while undergoing MRI scans. Participants will be randomly assigned to receive one of two anxiety management interventions:
- Innovision© infotainment system: This technology integrates visual and auditory distraction during MRIs to help patients maintain their calm and focus.
- Hypnosis: A guided method performed according to established hypnotic techniques to alleviate stress before or during MRI sessions.
To ensure data reliability and clinical compliance, all participants will evaluate their state anxiety outcomes through self-administered questionnaires at key time points.
Regulatory and clinical implications
The trial’s findings could influence future regulatory frameworks for medical device integration aimed at patient comfort. Leveraging devices like Innovision© demonstrates actionable pathways to minimize patient stress, which aligns with modern aims of medical device performance and safety outlined in MDR Annex XIV.
Additionally, adopting these interventions broadly could enhance diagnostic efficiency and reduce procedural interruptions caused by unmanaged anxiety. For healthcare providers, this means smoother workflows and potentially fewer rescheduled or invalid tests.
Regulatory specialists should monitor the approval mechanisms and reported outcomes, particularly from a clinical evaluation standpoint, as similar patient-support devices may become increasingly standardized based on this trial’s results.
FAQ about the clinical trial
1. What conditions are being studied?
The clinical trial focuses on managing unexpected anxiety in patients undergoing MRI sessions.
2. What interventions are being tested?
Two interventions are under evaluation: Innovision© infotainment systems and hypnosis techniques.
3. Who is sponsoring the study?
The study is sponsored by Centre Hospitalier Universitaire Dijon, a healthcare institution known for its research expertise.
4. When is recruitment expected to start?
The study is listed as “Not yet recruiting” and updates are anticipated in the near future.
5. Where can I learn more?
Details about the study are available via ClinicalTrials.gov, under study reference number NCT07246746.
Conclusion
The upcoming study exploring infotainment systems and hypnosis for managing MRI-related anxiety holds promise for reshaping patient care protocols in diagnostic imaging. For healthcare teams focused on quality assurance, regulatory specialists, and device manufacturers, this trial represents a pivotal opportunity to address a longstanding issue in diagnostic settings.
Stay updated as further details surrounding recruitment dates and interim findings become available through the primary sponsor, Centre Hospitalier Universitaire Dijon.
Disclaimer
This article provides informational content derived from publicly available clinical trial data. It does not constitute legal or regulatory advice. Stakeholders should consult qualified professionals for specific guidance.
Full announcement link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07246746?term=medical+device